{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T08:24:12Z","timestamp":1786955052353,"version":"build-2736575974"},"reference-count":99,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Allergic rhinitis (AR) has long been viewed as a type 2 inflammatory disease driven by IgE, mast cells and eosinophils. However, this classic model does not explain all clinical variation. Some patients continue to experience nasal congestion, nasal hyperreactivity and symptoms triggered by non-specific stimuli despite antihistamines, intranasal corticosteroids or allergen immunotherapy. Calcitonin gene-related peptide (CGRP), a potent vasodilatory neuropeptide mainly released by trigeminal sensory nerves, provides a plausible link between sensory activation, vascular responses, epithelial barrier function and immune-cell regulation. Here, we propose CGRP as a candidate neuroimmune amplifier in AR, while emphasizing that this concept remains a testable framework rather than an established causal pathway. The strongest AR-relevant evidence supports CGRP-mediated nasal vasodilation and obstruction. Evidence that CGRP directly amplifies human type 2 inflammation is more indirect and is partly extrapolated from airway, skin, gut and\n                    <jats:italic>in vitro<\/jats:italic>\n                    immune models. Current evidence mainly comes from nasal allergen challenge, neuropeptide measurement in nasal secretions, nasal mucosal tissue studies and intranasal CGRP challenge. CGRP biology is also context-dependent. In some settings, CGRP can suppress dendritic-cell activation or reshape T-cell and ILC2 responses, indicating that it should not be regarded as uniformly pro-inflammatory. Based on the success of CGRP-targeted drugs in migraine, local CGRP receptor antagonists may be useful tools to test a neurogenic AR endotype. These agents demonstrate pharmacological targetability, but not therapeutic efficacy in AR. Future studies should combine standardized nasal-secretion CGRP measurements with congestion-dominant symptoms, nasal hyperreactivity and objective airflow endpoints to determine whether a reproducible CGRP-high AR subgroup exists.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1910048","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T07:29:41Z","timestamp":1786951781000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Calcitonin gene-related peptide as a neuroimmune amplifier in allergic rhinitis: from disease worsening to targeted drug intervention"],"prefix":"10.3389","volume":"17","author":[{"given":"Yizuo","family":"Qubi","sequence":"first","affiliation":[{"name":"Yunnan University of Traditional Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Yunnan University of Traditional Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Yunnan University of Traditional Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuaner","family":"Mao","sequence":"additional","affiliation":[{"name":"Yunnan University of Traditional Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Qiu","sequence":"additional","affiliation":[{"name":"Yunnan University of Traditional Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Liu","sequence":"additional","affiliation":[{"name":"Yunnan University of Traditional Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Du","sequence":"additional","affiliation":[{"name":"Yunnan University of Traditional Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[{"name":"Yunnan University of Traditional Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minman","family":"Wu","sequence":"additional","affiliation":[{"name":"Yunnan University of Traditional Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41572-020-00227-0","article-title":"Allergic rhinitis","volume":"6","author":"Bousquet","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jaci.2019.06.049","article-title":"Next-generation allergic rhinitis and its impact on asthma guidelines for allergic rhinitis based on GRADE and real-world evidence","volume":"145","author":"Bousquet","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/alr.23090","article-title":"International consensus statement on allergy and rhinology: allergic rhinitis - 2023","volume":"13","author":"Wise","year":"2023","journal-title":"Int Forum Allergy Rhinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60130-X","article-title":"Allergic rhinitis","volume":"378","author":"Greiner","year":"2011","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI124609","article-title":"Neuro-immune crosstalk and allergic inflammation","volume":"129","author":"Kabata","year":"2019","journal-title":"J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.08.017","article-title":"Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms, and therapeutic targets in atopic diseases","volume":"153","author":"Kim","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1430760","article-title":"The role of nociceptive neurons in allergic rhinitis","volume":"15","author":"Cong","year":"2024","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxx040","article-title":"Neuro-immune interactions in allergic diseases: novel targets for therapeutics","volume":"29","author":"Voisin","year":"2017","journal-title":"Int Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00059.2021","article-title":"CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond","volume":"103","author":"Russo","year":"2023","journal-title":"Physiol Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0003-1","article-title":"CGRP as the target of new migraine therapies - successful translation from bench to clinic","volume":"14","author":"Edvinsson","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0091-6749(93)90043-f","article-title":"Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients","volume":"92","author":"Mosimann","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/BF00917475","article-title":"Mediation of prolonged increases in nasal mucosal blood flow by calcitonin gene-related peptide","volume":"10","author":"Rangi","year":"1990","journal-title":"J ClinImmunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1282130","article-title":"Neuroimmune communication in allergic rhinitis","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Neurol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/298240a0","article-title":"Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products","volume":"298","author":"Amara","year":"1982","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/304129a0","article-title":"Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing","volume":"304","author":"Rosenfeld","year":"1983","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: physiology and pathophysiology","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.1990.258.2.L81","article-title":"Calcitonin gene-related peptide in human nasal mucosa","volume":"258","author":"Baraniuk","year":"1990","journal-title":"Am J Physiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bph.14075","article-title":"Update on the pharmacology of calcitonin\/CGRP family of peptides: IUPHAR Review 25","volume":"175","author":"Hay","year":"2018","journal-title":"Br J Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0535-y","article-title":"Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor","volume":"561","author":"Liang","year":"2018","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1124\/pr.54.2.233","article-title":"International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors","volume":"54","author":"Poyner","year":"2002","journal-title":"Pharmacol Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41392-023-01464-x","article-title":"TRP ion channel family: structures, biological functions and therapeutic interventions for diseases","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/39807","article-title":"The capsaicin receptor: a heat-activated ion channel in the pain pathway","volume":"389","author":"Caterina","year":"1997","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(03)00158-2","article-title":"ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures","volume":"112","author":"Story","year":"2003","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/BF00917898","article-title":"Distinctive patterns of release of neuroendocrine peptides after nasal challenge of allergic subjects with ryegrass antigen","volume":"8","author":"Walker","year":"1988","journal-title":"J ClinImmunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/BF02114752","article-title":"Neutral endopeptidase activity and concentration of sensory neuropeptide in the human nasal mucosa","volume":"252","author":"Lacroix","year":"1995","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/000348949910801008","article-title":"Expression of NPY Y1 and CGRP1 receptors in human nasal mucosa: implications in allergic rhinitis","volume":"108","author":"Uddman","year":"1999","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/apha.12442","article-title":"Calcitonin gene-related peptide: key regulator of cutaneous immunity","volume":"213","author":"Granstein","year":"2015","journal-title":"Acta Physiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2021.100540","article-title":"Naso-ocular neuropeptide interactions in allergic rhinoconjunctivitis, rhinitis, and conjunctivitis","volume":"14","author":"Meng","year":"2021","journal-title":"World Allergy Organ J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/00016489850183502","article-title":"Distribution and quantity of neuroendocrine markers in allergic rhinitis","volume":"118","author":"Fang","year":"1998","journal-title":"Acta Otolaryngol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2004.01990.x","article-title":"Phenotypic alteration of neuropeptide-containing nerve fibres in seasonal intermittent allergic rhinitis","volume":"34","author":"Heppt","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2016.05.015","article-title":"Persistent nasal symptoms and mediator release after continuous pollen exposure in an environmental challenge chamber","volume":"117","author":"Okuma","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B33","article-title":"Calcitonin gene-related peptide nasal provocation in humans","volume":"72","author":"Guarnaccia","year":"1994","journal-title":"Ann Allergy"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1985.tb11107.x","article-title":"Inflammatory oedema induced by synergism between calcitonin gene-related peptide and mediators of increased vascular permeability","volume":"86","author":"Brain","year":"1985","journal-title":"Br J Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2026.1766176","article-title":"A systematic review and meta-analysis on the risk of migraine in patients with allergic rhinitis","volume":"13","author":"Wu","year":"2026","journal-title":"Front Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4168\/aair.2023.15.1.55","article-title":"Atopic disorders and their risks of migraine: a nationwide population-based cohort study","volume":"15","author":"Han","year":"2023","journal-title":"Allergy Asthma Immunol Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10194-023-01569-2","article-title":"Shared and independent roles of CGRP and PACAP in migraine pathophysiology","volume":"24","author":"Kuburas","year":"2023","journal-title":"J Headache Pain"},{"key":"B38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40001-024-01682-1","article-title":"No causal association between allergic rhinitis and migraine: a Mendelian randomization study","volume":"29","author":"Lv","year":"2024","journal-title":"Eur J Med Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.02.016","article-title":"The basic immunology of asthma","volume":"184","author":"Hammad","year":"2021","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/363159a0","article-title":"Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide","volume":"363","author":"Hosoi","year":"1993","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.1.607","article-title":"Negative regulation of TLR responses by the neuropeptide CGRP is mediated by the transcriptional repressor ICER","volume":"179","author":"Harzenetter","year":"2007","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086367","article-title":"Calcitonin gene-related peptide regulates type IV hypersensitivity through dendritic cell functions","volume":"6","author":"Mikami","year":"2011","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.immuni.2019.06.009","article-title":"Neuropeptide CGRP limits group 2 innate lymphoid cell responses and constrains type 2 inflammation","volume":"51","author":"Nagashima","year":"2019","journal-title":"Immunity"},{"key":"B44","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.immuni.2019.09.004","article-title":"Transcriptional atlas of intestinal immune cells reveals that neuropeptide alpha-CGRP modulates group 2 innate lymphoid cell responses","volume":"51","author":"Xu","year":"2019","journal-title":"Immunity"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan8546","article-title":"Pulmonary neuroendocrine cells amplify allergic asthma responses","volume":"360","author":"Sui","year":"2018","journal-title":"Science"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12780","article-title":"Pathogenesis of rhinitis","volume":"46","author":"Eifan","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102486","article-title":"Allergic rhinitis: pathophysiology and treatment focusing on mast cells","volume":"10","author":"Zoabi","year":"2022","journal-title":"Biomedicines"},{"key":"B48","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000336523","article-title":"The mast cell-nerve functional unit: a key component of physiologic and pathophysiologic responses","volume":"98","author":"Forsythe","year":"2012","journal-title":"Chem Immunol Allergy"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0493-z","article-title":"House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation","volume":"20","author":"Serhan","year":"2019","journal-title":"Nat Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/72247","article-title":"Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism","volume":"6","author":"Steinhoff","year":"2000","journal-title":"Nat Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/all.14835","article-title":"Effect of intranasal corticosteroid treatment on allergen-induced changes in group 2 innate lymphoid cells in allergic rhinitis with mild asthma","volume":"76","author":"Xie","year":"2021","journal-title":"Allergy"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxaf060","article-title":"Role of group 2 innate lymphoid cells in intranasal sensitization-induced allergic rhinitis in mice","volume":"38","author":"Kato","year":"2026","journal-title":"Int Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.586078","article-title":"The role of type 2 innate lymphoid cells in allergic diseases","volume":"12","author":"Zheng","year":"2021","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00704-5","article-title":"Heterogeneity of type 2 innate lymphoid cells","volume":"22","author":"Spits","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nature23676","article-title":"The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation","volume":"549","author":"Klose","year":"2017","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nature24029","article-title":"The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation","volume":"549","author":"Wallrapp","year":"2017","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.immuni.2020.10.001","article-title":"Substance P release by sensory neurons triggers dendritic cell migration and initiates the type-2 immune response to allergens","volume":"53","author":"Perner","year":"2020","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.anai.2026.03.013","article-title":"A single-cell atlas of the human airways from patients with allergic rhinitis comorbid with asthma","volume":"136","author":"Xiao","year":"2026","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8085615","article-title":"Elevated levels of activated and pathogenic eosinophils characterize moderate-severe house dust mite allergic rhinitis","volume":"2020","author":"Chen","year":"2020","journal-title":"J Immunol Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2024.100930","article-title":"Blood and local eosinophil levels in chronic rhinitis: observations during seasonal allergen exposure and non-exposure","volume":"17","author":"Xu","year":"2024","journal-title":"World Allergy Organ J"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.149.10.3309","article-title":"Neuropeptides modulate human eosinophil chemotaxis","volume":"149","author":"Numao","year":"1992","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.64.6.828","article-title":"Signaling in neuropeptide-induced migration of human eosinophils","volume":"64","author":"Dunzendorfer","year":"1998","journal-title":"J Leukoc Biol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00570","article-title":"Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity","volume":"5","author":"Davoine","year":"2014","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00538-7","article-title":"Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions","volume":"21","author":"Akdis","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00477-9","article-title":"Regulation of immune responses by the airway epithelial cell landscape","volume":"21","author":"Hewitt","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jaci.2017.08.039","article-title":"Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis","volume":"141","author":"Steelant","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/all.14132","article-title":"Nasal epithelial barrier dysfunction increases sensitization and mast cell degranulation in the absence of allergic inflammation","volume":"75","author":"Kortekaas Krohn","year":"2020","journal-title":"Allergy"},{"key":"B68","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1016\/j.cell.2022.09.024","article-title":"Nociceptor neurons direct goblet cells via a CGRP-RAMP1 axis to drive mucus production and gut barrier protection","volume":"185","author":"Yang","year":"2022","journal-title":"Cell"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/313054a0","article-title":"Calcitonin gene-related peptide is a potent vasodilator","volume":"313","author":"Brain","year":"1985","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/all.15259","article-title":"Epithelial and sensory mechanisms of nasal hyperreactivity","volume":"77","author":"Velasco","year":"2022","journal-title":"Allergy"},{"key":"B71","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4193\/Rhin23.287","article-title":"Nasal hyperreactivity in allergic rhinitis and chronic rhinosinusitis with polyps: a role for neuronal pathways","volume":"62","author":"Backaert","year":"2024","journal-title":"Rhinology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07869-0","article-title":"A gamma-delta T cell-IL-3 axis controls allergic responses through sensory neurons","volume":"634","author":"Flayer","year":"2024","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1998.84.2.537","article-title":"Plasma extravasation through neuronal stimulation in human nasal mucosa in the setting of allergic rhinitis","volume":"84","author":"Sanico","year":"1998","journal-title":"J Appl Physiol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.11.027","article-title":"Mechanisms underlying the neuronal-based symptoms of allergy","volume":"133","author":"Undem","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.10.048","article-title":"A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: involvement of TRPV1 and TRPA1","volume":"133","author":"Cevikbas","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12931-024-02702-8","article-title":"The airway neuro-immune axis as a therapeutic target in allergic airway diseases","volume":"25","author":"Wu","year":"2024","journal-title":"Respir Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705848","article-title":"A controlled trial of erenumab for episodic migraine","volume":"377","author":"Goadsby","year":"2017","journal-title":"N Engl J Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709038","article-title":"Fremanezumab for the preventive treatment of chronic migraine","volume":"377","author":"Silberstein","year":"2017","journal-title":"N Engl J Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.1212","article-title":"Evaluation of galcanezumab for the prevention of episodic migraine: the EVOLVE-1 randomized clinical trial","volume":"75","author":"Stauffer","year":"2018","journal-title":"JAMA Neurol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009169","article-title":"Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2","volume":"94","author":"Lipton","year":"2020","journal-title":"Neurology"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1111\/head.14692","article-title":"Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: an American Headache Society position statement update","volume":"64","author":"Charles","year":"2024","journal-title":"Headache"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.973226","article-title":"Cranial autonomic symptoms and response to monoclonal antibodies targeting the calcitonin gene-related peptide pathway: a real-world study","volume":"13","author":"De Matteis","year":"2022","journal-title":"Front Neurol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11061656","article-title":"New generation gepants: migraine acute and preventive medications","volume":"11","author":"Moreno-Ajona","year":"2022","journal-title":"J Clin Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31606-X","article-title":"Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine","volume":"394","author":"Croop","year":"2019","journal-title":"Lancet"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1721462","article-title":"Ubrogepant for the treatment of migraine","volume":"21","author":"Curto","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30234-9","article-title":"Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b\/3 trial","volume":"19","author":"Goadsby","year":"2020","journal-title":"Lancet Neurol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/head.14389","article-title":"Zavegepant nasal spray for the acute treatment of migraine: a Phase 2\/3 double-blind, randomized, placebo-controlled, dose-ranging trial","volume":"62","author":"Croop","year":"2022","journal-title":"Headache"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00517-8","article-title":"Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial","volume":"22","author":"Lipton","year":"2023","journal-title":"Lancet Neurol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01885-6","article-title":"Zavegepant: first approval","volume":"83","author":"Dhillon","year":"2023","journal-title":"Drugs"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010591.pub2","article-title":"Capsaicin for non-allergic rhinitis","volume":"2015","author":"Gevorgyan","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B91","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jaci.2017.03.014","article-title":"Enhanced chemosensory sensitivity in patients with idiopathic rhinitis and its reversal by nasal capsaicin treatment","volume":"140","author":"Van Gerven","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1093925","article-title":"Inflammation-the role of TRPA1 channel","volume":"14","author":"Yao","year":"2023","journal-title":"Front Physiol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/head.14153","article-title":"The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice","volume":"61","author":"Ailani","year":"2021","journal-title":"Headache"},{"key":"B94","doi-asserted-by":"publisher","first-page":"24","DOI":"10.22514\/jofph.2024.036","article-title":"Assessing the occurrence of hypertension in patients receiving calcitonin gene-related peptide monoclonal antibodies for episodic and chronic migraine: a systematic review and meta-analysis","volume":"38","author":"Di","year":"2024","journal-title":"J Oral Facial Pain Headache"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241273966","article-title":"Case series on monoclonal antibodies targeting CGRP in migraine patients during pregnancy: enhancing safety data","volume":"44","author":"Elosua-Bayes","year":"2024","journal-title":"Cephalalgia"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.04.021","article-title":"The nasal basal cell population shifts toward a diseased phenotype with impaired barrier formation capacity in allergic rhinitis","volume":"154","author":"Ruysseveldt","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jaci.2023.06.026","article-title":"Nasal IL-13 production identifies patients with late-phase allergic responses","volume":"152","author":"Campion","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2023.100801","article-title":"Birch-induced allergic rhinitis: results of exposure during nasal allergen challenge, environmental chamber, and pollen season","volume":"16","author":"Gherasim","year":"2023","journal-title":"World Allergy Organ J"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1111\/all.16174","article-title":"Multi-omic integration reveals alterations in nasal mucosal biology that mediate air pollutant effects on allergic rhinitis","volume":"79","author":"Irizar","year":"2024","journal-title":"Allergy"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1910048\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T07:29:43Z","timestamp":1786951783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1910048\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":99,"alternative-id":["10.3389\/fimmu.2026.1910048"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1910048","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"article-number":"1910048"}}